BackDOD Biotech Public , Ltd. Overview

DOD Biotech Public , Ltd. Receivables

Track DOD Biotech Public , Ltd.'s receivables ($83M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$82.95M
↑ 39.53% YoYΔ $23.50M vs prior year quarter

Peer trimmed avg / median

Loading

DOD Biotech Public , Ltd. Receivables History

Loading

DOD Biotech Public , Ltd. vs. peers: Receivables Comparison

Loading

DOD Biotech Public , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

DOD Biotech Public , Ltd. (DOD.BK) FAQ

As of the most recent data (June 2026), DOD.BK shows a receivables of $83M. That compares with $59M in the prior-year period — up 39.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DOD.BK's receivables is now $83M (was $59M) — a 39.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether DOD Biotech Public , Ltd. is outperforming or lagging.

Tracking DOD.BK's receivables over time shows whether DOD Biotech Public , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $83M That compares with $59M in the prior-year period — up 39.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has DOD Biotech Public , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $83M) with ownership activity and broader fundamentals.